Clinical Trial Update: Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder [Phase 2, Phase 3]

View source ↗

Summary

The Phase 2/3 trial comparing Bryophyllum Pinnatum, Solifenacin, and placebo for overactive bladder was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urge Urinary Incontinence

Drugs mentioned

• Bryophyllum pinnatum (Bryophyllum pinnatum extract)
• Solifenacin (solifenacin)

Snippet

Sponsor: University of Zurich | Conditions: Overactive Bladder, Urge Urinary Incontinence | Phase 2, Phase 3 | Status: TERMINATED